Aksa Akrilik Kimya Sanayi AS (AKSA) fair value: what the stock is really worth
As of Oct 28, 2026: fair value (intrinsic value) of Aksa Akrilik Kimya Sanayi AS stock TRY 8.98, price TRY 10.37, upside -13.4%, quality 36 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value 30%+ above price?No
Quality 50+?No
In an uptrend?No
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Oct 27, 2026.
How to read this chart
60‑month range 1.16 TRY – 12.59 TRY · fair‑value band 6.80 TRY – 11.27 TRY · the 10.37 TRY price screens above the 8.98 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Oct 27, 2026.
Follow Aksa Akrilik Kimya Sanayi AS in your weekly email
Every Wednesday you see whether Aksa Akrilik Kimya Sanayi AS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Aksa Akrilik Kimya Sanayii A.S., together with its subsidiaries, manufactures and sells textiles, chemicals, and other industrial products in Turkey and internationally. It operates through Fibers, Energy, Advanced Material, and Other segments.
Show moreShow less
The company offers acrylic fibers, textile fibers, outdoor fibers, industrial fibers, acrylic filament, modacrylic fibers, recycled fiber, aksafil yarn, acrybella, and polyethylene fiber.
It also provides textile and technical textile raw materials for carpets, upholstery, sweaters, socks, velvet, rugs, blankets, tents, and industrial filters; carbon fiber and carbon fiber-reinforced composite solutions; artificial, synthetic, natural fibers, carbon fibers, filaments, yarns, and polymers.
In addition, the company is involved in production, processing, storage, import, export, marketing, and trading of products, raw materials, auxiliary materials, and intermediates; production, supply, and trading of machinery, equipment, facilities, and spare parts; establishment, operation, and leasing of power generation facilities; production and sale of electricity, as well as production, supply, trading, import, export, and research and development activities related to aircraft, helicopters, display aircraft, gliders, motorized and non-motorized parachutes, and other equipment for the aviation and defense industries.
Aksa Akrilik Kimya Sanayii A.S. was founded in 1968 and is headquartered in Yalova, Turkey.
Stock analysis
Aksa Akrilik Kimya Sanayi AS (AKSA) currently trades at 10.37 TRY, while our model-based Fair Value estimate is 8.98 TRY, 13.4% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 17.18 TRY per share, and 6 of the 24 models we run sit above the 10.37 TRY price.
Bear case: the Earnings-Based group reads lowest at 2.95 TRY, and 18 of the 24 models stay below the price. Data coverage for this calculation is low.
Scenario range: 6.80 TRY (bear) to 11.27 TRY (bull), the price of 10.37 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Consumer Cyclical sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Aksa Akrilik Kimya Sanayi AS reported revenue of 32.4B TRL in FY2025 versus 8.3B TRL in FY2021, a compound +40.4%/yr. Reported net income was 4.0B TRL in FY2025, compounding +36.2%/yr from FY2021.
Key figures
Market cap 40.3B TRY (≈ $808M) Small · P/E ratio 6.9 · P/S ratio 1.11 · EPS (TTM) 1.50 TRY · Dividend yield 5.3% · Net margin 16.0% · Return on equity 17.1% · Return on assets (EBIT) 15.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (medium confidence).
What moves the price
The share trades about 18% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −3% fair-value upside, at −13%, AKSA screens richer than that median.
Fair Value models
Bear6.80 TRYFair Value 8.98 TRYBull11.27 TRY
Price 10.37 TRY · Upside -13.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (1.24 TRY per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.80/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−12.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+23.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+51.2%
Start year 2020 (pandemic). Over 10 years: +31.9% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−29.4%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−0.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−5.4%
Dividend (yield on the price)5.3%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 8%
⚠ Revenue per share shrinking 2.5%/yr over ~6Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+32.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about +10.9% a year for the price.
Compare Aksa Akrilik Kimya Sanayi AS with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 342 stocks
Beats the industry median on 9/15 measures
Overall it ranks above its industry peers.
Valuation
Quality Score36 · Bottom 25%
Fair Value upside−13.4% · Above median
Profitability
Return on equity (12 months)17.1% · Top 25%
Return on assets5.9% · Top 25%
Net margin (12 months)16.0% · Top 25%
Operating margin (12 months)4.1% · Below median
Growth and dividend
Revenue growth (quarter YoY)22.0% · Top 25%
Dividend yield (12 months)5.3% · Top 25%
Balance sheet
Debt / equity0.23× · Above median
Valuation Multiplesvs Textile Manufacturing median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Aksa Akrilik Kimya Sanayi AS Fair Value". https://www.fairvalue-calculator.com/stock/AKSA
Frequently asked questions
Is Aksa Akrilik Kimya Sanayi AS (AKSA) overvalued or undervalued?
As of Oct 27, 2026, our model estimates a fair value of 8.98 TRY versus a price of 10.37 TRY, about −13% upside (overvalued).
What is the fair value of AKSA?
Our model-based fair value for Aksa Akrilik Kimya Sanayi AS is 8.98 TRY (as of Oct 27, 2026), built from audited fundamentals. The current price: 10.37 TRY.
What is the quality score of AKSA?
Aksa Akrilik Kimya Sanayi AS has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Aksa Akrilik Kimya Sanayi AS (AKSA)?
Our model-based price target is the fair value of 8.98 TRY (as of Oct 27, 2026) from 24 valuation models. Cautious scenario 6.80 TRY, optimistic scenario 11.27 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Aksa Akrilik Kimya Sanayi AS stock forecast for 2026?
Our models put fair value at 8.98 TRY, about −13% upside versus a price of 10.37 TRY (overvalued). Cautious scenario 6.80 TRY, optimistic scenario 11.27 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Aksa Akrilik Kimya Sanayi AS (AKSA)?
Aksa Akrilik Kimya Sanayi AS reported trailing-twelve-month revenue of about 36.3B TRY (latest available figure, as of Oct 27, 2026).
Does Aksa Akrilik Kimya Sanayi AS pay a dividend?
Aksa Akrilik Kimya Sanayi AS currently shows a dividend yield of 5.33% relative to its recent price (as of Oct 27, 2026).
What growth is priced into Aksa Akrilik Kimya Sanayi AS (AKSA)?
For today's price to be fair in a discounted-cash-flow model, Aksa Akrilik Kimya Sanayi AS would have to grow free cash flow by +32.3 % per year for five years (discount rate 15.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +51.2 % per year. As of Oct 27, 2026.
What discount rate (WACC) does the fair value of AKSA use?
Our models discount Aksa Akrilik Kimya Sanayi AS at 15.7 %: a base by market capitalisation (small), country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Aksa Akrilik Kimya Sanayi AS that is +32.3 % per year a year over ten years, using the same discount rate (15.7 %) and the same formula as our fair value.
How much growth has Aksa Akrilik Kimya Sanayi AS (AKSA) delivered so far?
Over the past 5 years revenue at Aksa Akrilik Kimya Sanayi AS grew +51.2 % a year. The price currently implies +32.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Aksa Akrilik Kimya Sanayi AS (AKSA) growing?
The median revenue growth in the sector is +4.7 % a year. That is the yardstick for the growth priced into Aksa Akrilik Kimya Sanayi AS (+32.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The free-cash-flow yield on the price is 4.84 %: that much free cash flow Aksa Akrilik Kimya Sanayi AS produces per unit of market value. When it exceeds the discount rate of our models (15.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Aksa Akrilik Kimya Sanayi AS (AKSA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Aksa Akrilik Kimya Sanayi AS it is 8.98 TRY per share (as of Oct 27, 2026), against a price of 10.37 TRY. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Aksa Akrilik Kimya Sanayi AS stock overvalued or undervalued in 2026?
As of Oct 27, 2026, AKSA trades above its calculated fair value: price 10.37 TRY, fair value 8.98 TRY, a gap of about −13% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AKSA?
No. The price is what the market pays today (10.37 TRY); the fair value is what the company's own numbers justify (8.98 TRY). For Aksa Akrilik Kimya Sanayi AS the two are 1.39 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Aksa Akrilik Kimya Sanayi AS worth?
The market values Aksa Akrilik Kimya Sanayi AS at about 40.3B TRY (market capitalisation, as of Oct 27, 2026). Per share that is 10.37 TRY; our models calculate a fair value of 8.98 TRY per share.
What do the bullish and bearish scenarios say about AKSA?
Our models span a range for Aksa Akrilik Kimya Sanayi AS: cautious scenario 6.80 TRY, base 8.98 TRY, optimistic 11.27 TRY per share (as of Oct 27, 2026, price 10.37 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AKSA?
Aksa Akrilik Kimya Sanayi AS trades at a price-to-earnings ratio of 6.9 (as of Oct 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 8.98 TRY is built from several models across several years. Other multiples: PEG 0.3, P/B 1.2, P/S 1.1, EV/EBITDA 5.8.
What is the PEG ratio of AKSA?
The PEG ratio of Aksa Akrilik Kimya Sanayi AS is 0.32 (P/E divided by earnings growth, as of Oct 27, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Aksa Akrilik Kimya Sanayi AS (AKSA)?
Balance-sheet figures for Aksa Akrilik Kimya Sanayi AS (as of Oct 27, 2026): return on equity 17.1%, debt of 0.23 per unit of equity. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is AKSA from its 52-week high?
Aksa Akrilik Kimya Sanayi AS trades at 10.37 TRY, about 18% below its 52-week high of 12.59 TRY and 13% above the low of 9.21 TRY (as of Oct 28, 2026). Distance from the high says nothing about value: that is what the fair value of 8.98 TRY is for.
Which stocks are comparable to Aksa Akrilik Kimya Sanayi AS?
From the same area (Consumer Cyclical) we also value Tongkun Group, Inner Mongolia ERDOS Resources Co, Far Eastern New Century Corporation, K.P.R. Mill Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Aksa Akrilik Kimya Sanayi AS stock attractive at the current price?
The data as of Oct 27, 2026: price 10.37 TRY, calculated fair value 8.98 TRY (−13%), Quality Score 36/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AKSA calculated?
We run Aksa Akrilik Kimya Sanayi AS through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 8.98 TRY, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.4 % above its aggregate fair value. Aksa Akrilik Kimya Sanayi AS itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The closing price on Oct 28, 2026 was 10.37 TRY. Our model-based fair value is 8.98 TRY, about −13% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Aksa Akrilik Kimya Sanayi AS right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. The price sits in the upper half of our model range, so the margin of safety is thin. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of Aksa Akrilik Kimya Sanayi AS
How large is the market capitalisation of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The market capitalisation of Aksa Akrilik Kimya Sanayi AS is 40.3B TRY (≈ $808M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The price-to-sales ratio of Aksa Akrilik Kimya Sanayi AS is 1.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Aksa Akrilik Kimya Sanayi AS (AKSA)?
Earnings per share at Aksa Akrilik Kimya Sanayi AS are 1.50 TRY (price ÷ EPS = P/E 6.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The dividend yield of Aksa Akrilik Kimya Sanayi AS is 5.3% (payout 36.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The net margin of Aksa Akrilik Kimya Sanayi AS is 16.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The return on equity (ROE) of Aksa Akrilik Kimya Sanayi AS is 17.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Aksa Akrilik Kimya Sanayi AS (AKSA)?
On an EBIT basis the return on assets of Aksa Akrilik Kimya Sanayi AS is 15.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Aksa Akrilik Kimya Sanayi AS (AKSA)?
The operating margin of Aksa Akrilik Kimya Sanayi AS is 4.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Aksa Akrilik Kimya Sanayi AS (AKSA)?
Revenue at Aksa Akrilik Kimya Sanayi AS is growing +22.0% versus a year earlier (3y avg +23.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Aksa Akrilik Kimya Sanayi AS (AKSA)?
Earnings per share at Aksa Akrilik Kimya Sanayi AS are growing +133% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Aksa Akrilik Kimya Sanayi AS (AKSA) carry?
The net debt of Aksa Akrilik Kimya Sanayi AS is 21.1B TRY (fiscal year 2025, ≈ 10.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Aksa Akrilik Kimya Sanayi AS in the live analysis
One click puts Aksa Akrilik Kimya Sanayi AS on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 27, 2026